Advertisement

Topics

A novel research partnership in AI to advance drug discovery, longevity & aging research

20:00 EDT 13 Jun 2018 | AAAS

(Biogerontology Research Foundation) Thursday, June 14, London, UK: Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intelligence for drug discovery. The collaboration will also cover the many novel biological targets implicated in aging and age-related diseases. The Biogerontology Research Foundation salutes its Chief Science Officer, Dr. Alex Zhavoronkov, on the announcement of a research collaboration.

Original Article: A novel research partnership in AI to advance drug discovery, longevity & aging research

NEXT ARTICLE

More From BioPortfolio on "A novel research partnership in AI to advance drug discovery, longevity & aging research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...